Preliminary research point out conolidine may inhibit specific ion channels, cutting down neuronal excitability and restricting discomfort indicators. This system is especially appropriate in neuropathic agony, where by abnormal signaling triggers persistent soreness. Also, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to soreness perception. Comp... https://hansy044eig7.wikigdia.com/user